Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 4
2011 3
2012 2
2013 3
2014 3
2015 2
2016 5
2017 2
2018 1
2019 5
2020 5
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.
Huebner H, Häberle L, Müller V, Schrader I, Lorenz R, Forstbauer H, Fink V, Schochter F, Bekes I, Mahner S, Jückstock J, Nabieva N, Schneeweiss A, Tesch H, Brucker SY, Blohmer JU, Fehm TN, Heinrich G, Rezai M, Beckmann MW, Fasching PA, Janni W, Rack B. Huebner H, et al. Among authors: juckstock j. Cancers (Basel). 2022 Mar 28;14(7):1721. doi: 10.3390/cancers14071721. Cancers (Basel). 2022. PMID: 35406491 Free PMC article.
Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial.
Devlieger R, Buxmann H, Nigro G, Enders M, Jückstock J, Siklós P, Wartenberg-Demand A, Schüttrumpf J, Schütze J, Rippel N, Herbold M, Niemann G, Friese K. Devlieger R, et al. Among authors: juckstock j. Fetal Diagn Ther. 2021;48(8):611-623. doi: 10.1159/000518508. Epub 2021 Sep 21. Fetal Diagn Ther. 2021. PMID: 34569538 Free PMC article. Clinical Trial.
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.
Friedl TWP, Fehm T, Müller V, Lichtenegger W, Blohmer J, Lorenz R, Forstbauer H, Fink V, Bekes I, Huober J, Jückstock J, Schneeweiss A, Tesch H, Mahner S, Brucker SY, Heinrich G, Häberle L, Fasching PA, Beckmann MW, Coleman RE, Janni W, Rack B. Friedl TWP, et al. Among authors: juckstock j. JAMA Oncol. 2021 Aug 1;7(8):1149-1157. doi: 10.1001/jamaoncol.2021.1854. JAMA Oncol. 2021. PMID: 34165508 Free PMC article. Clinical Trial.
Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
Beilner D, Kuhn C, Kost BP, Vilsmaier T, Vattai A, Kaltofen T, Mahner S, Schmoeckel E, Dannecker C, Jückstock J, Mayr D, Jeschke U, Heidegger HH. Beilner D, et al. Among authors: juckstock j. Arch Gynecol Obstet. 2021 Nov;304(5):1307-1314. doi: 10.1007/s00404-021-06053-3. Epub 2021 Apr 16. Arch Gynecol Obstet. 2021. PMID: 33861372 Free PMC article.
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer.
Beilner D, Kuhn C, Kost BP, Jückstock J, Mayr D, Schmoeckel E, Dannecker C, Mahner S, Jeschke U, Heidegger HH. Beilner D, et al. Among authors: juckstock j. J Cancer Res Clin Oncol. 2020 Nov;146(11):2843-2850. doi: 10.1007/s00432-020-03338-z. Epub 2020 Jul 28. J Cancer Res Clin Oncol. 2020. PMID: 32725356 Free PMC article.
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Klapdor R, Hillemanns P, Wölber L, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst S, Strauss H, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeld B, Mahner S. Klapdor R, et al. Among authors: juckstock j. Int J Gynecol Cancer. 2020 Jul;30(7):920-926. doi: 10.1136/ijgc-2019-001187. Epub 2020 May 28. Int J Gynecol Cancer. 2020. PMID: 32467335
[Often not requiring therapy].
Jückstock J, Blankenstein T, Weiß F, Mahner S. Jückstock J, et al. MMW Fortschr Med. 2020 Jan;162(1):60-61. doi: 10.1007/s15006-020-0063-1. MMW Fortschr Med. 2020. PMID: 31960301 Review. German. No abstract available.
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
Woelber L, Eulenburg C, Kosse J, Neuser P, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Jückstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fürst S, Strauss HG, Mahner S, Prieske K; AGO-CaRE 1 investigators. Woelber L, et al. Among authors: juckstock j. Gynecol Oncol. 2019 Sep;154(3):571-576. doi: 10.1016/j.ygyno.2019.07.009. Epub 2019 Jul 17. Gynecol Oncol. 2019. PMID: 31324454
38 results